NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of WPP plc ("WPP" or the "Company") (NASDAQ:WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether WPP and certain of its officers and/or directors […]
NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ:RARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ultragenyx and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. ("Simulations Plus" or the "Company") (NASDAQ:SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Simulations Plus and certain of its
NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Necessity Retail REIT, Inc. ("Necessity Retail" or the "Company") (NASDAQ:RTL) who received shares of Global Net Lease, Inc. ("Global Net Lease") in connection with Global Net Lease’s acquisition of Necessity Retail on September
NEW YORK, NY / ACCESS Newswire / August 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of GSK plc ("GSK" or the "Company") (NYSE:GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GSK and certain of its officers and/or directors have
NEW YORK, NY / ACCESS Newswire / August 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Charter Communications, Inc. ("Charter" or the "Company") (NASDAQ:CHTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Charter and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Tronox Holdings plc ("Tronox" or the "Company") (NYSE:TROX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Tronox and certain of its officers and/or
The trophon®3 device and trophon2 Plus are now available in the U.S. and Canada. Nanosonics, Inc., a global leader in infection prevention solutions, is proud to announce the release of the trophon3 system and trophon2 Plus, a software upgrade available for the trophon2 device. https://mma.prnewswire.com/media/2560853/Nanosonics_Logo.jpg The trophon device is the only automated HLD system for
NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ:CFLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Confluent and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 14, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Lockheed Martin Corporation ("Lockheed" or the "Company") (NYSE:LMT).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are